126 related articles for article (PubMed ID: 29966468)
1. Bone marrow-derived mesenchymal stem/stromal cells from patients with splenic marginal zone lymphoma are intrinsically impaired and influence the malignant B-cells.
Pontikoglou C; Kalyva A; Kalpadakis C; Velegraki M; Bizymi N; Alpantaki K; Kontakis G; Pangalis GA; Papadaki HA
Leuk Lymphoma; 2019 Feb; 60(2):538-540. PubMed ID: 29966468
[No Abstract] [Full Text] [Related]
2. Hyperviscosity syndrome in splenic marginal zone lymphoma.
Daniel R; Chan RY
Blood; 2018 Oct; 132(15):1627. PubMed ID: 30309878
[No Abstract] [Full Text] [Related]
3. Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation.
Bastidas-Mora G; Beà S; Navarro A; Gine E; Costa D; Delgado J; Baumann T; Magnano L; Rivas-Delgado A; Villamor N; Colomer D; Lopez-Guerra M; Rozman M; Balagué O; Martínez D; Baptista MJ; Escoda L; Alcoceba M; Blanes M; Climent F; Campo E; Wotherspoon A; López-Guillermo A; Matutes E
Br J Haematol; 2022 Jan; 196(1):146-155. PubMed ID: 34519021
[TBL] [Abstract][Full Text] [Related]
4. Splenic marginal zone lymphoma in a HIV-1 infected patient: evidence favouring a pathogenetic role of HIV-1 itself in the lymphomagenesis.
Cagliuso M; Conti V; Trasarti S; Lombardi L; Riminucci M; Perez M; Turriziani O; Falasca F; Nanni M; Tafuri A; Mezzaroma I
Infection; 2013 Feb; 41(1):255-8. PubMed ID: 23007326
[TBL] [Abstract][Full Text] [Related]
5. A peculiar case of splenic marginal zone lymphoma and review of literature.
Mishra MN; Pandey R; Dinda A; Nityanand S
Iran J Immunol; 2013 Sep; 10(3):186-9. PubMed ID: 24076596
[No Abstract] [Full Text] [Related]
6. Splenic marginal zone lymphoma: current knowledge and future directions.
Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
[TBL] [Abstract][Full Text] [Related]
7. Remission of splenic marginal zone lymphoma in a patient treated for hepatitis B: a case of HBV-associated lymphoma.
Koot AW; Visscher AP; Huits RM
Acta Clin Belg; 2015 Aug; 70(4):301-3. PubMed ID: 25977147
[TBL] [Abstract][Full Text] [Related]
8. Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis.
Vase MØ; Hellberg YK; Larsen CS; Petersen E; Schaumburg H; Bendix K; Ravel C; Bastien P; Christensen M; d'Amore F
Acta Haematol; 2012; 128(1):20-2. PubMed ID: 22572474
[No Abstract] [Full Text] [Related]
9. NOTCH signaling in the pathogenesis of splenic marginal zone lymphoma-opportunities for therapy.
Alderuccio JP; Lossos IS
Leuk Lymphoma; 2022 Feb; 63(2):279-290. PubMed ID: 34586000
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma.
Franco G; Guarnotta C; Frossi B; Piccaluga PP; Boveri E; Gulino A; Fuligni F; Rigoni A; Porcasi R; Buffa S; Betto E; Florena AM; Franco V; Iannitto E; Arcaini L; Pileri SA; Pucillo C; Colombo MP; Sangaletti S; Tripodo C
Blood; 2014 Mar; 123(12):1836-49. PubMed ID: 24452203
[TBL] [Abstract][Full Text] [Related]
11. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
[TBL] [Abstract][Full Text] [Related]
12. A Single-center Experience in Splenic Diffuse Red Pulp Lymphoma Diagnosis.
Julhakyan HL; Al-Radi LS; Moiseeva TN; Danishyan KI; Kovrigina AM; Glebova SM; Lugovskaya SA; Dvirnik VN; Khvastunova AN; Yakutik IA; Savchenko VG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S166-9. PubMed ID: 27131623
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?
Ponzoni M; Kanellis G; Pouliou E; Baliakas P; Scarfò L; Ferreri AJ; Doglioni C; Bikos V; Dagklis A; Anagnostopoulos A; Ghia P; Stamatopoulos K; Papadaki T
Am J Surg Pathol; 2012 Nov; 36(11):1609-18. PubMed ID: 23073320
[TBL] [Abstract][Full Text] [Related]
14. Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical use.
Montalban C; Abraira V; Arcaini L; Domingo-Domenech E; Guisado-Vasco P; Iannitto E; Mollejo M; Matutes E; Ferreri AJ; Salar A; Rattotti S; Carpaneto A; Perez R; Bello JL; Hernandez M; Caballero D; Carbonell F; Piris MA;
Leuk Lymphoma; 2014 Apr; 55(4):929-31. PubMed ID: 23799931
[No Abstract] [Full Text] [Related]
15. Clinical and biological diversity of splenic marginal zone lymphoma.
Matutes E
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1185-9. PubMed ID: 19761421
[No Abstract] [Full Text] [Related]
16. Idelalisib and Rituximab in 17p Deletion-Positive Splenic Marginal Zone Lymphoma.
Philip AZ
J Natl Compr Canc Netw; 2018 Mar; 16(3):230-233. PubMed ID: 29523661
[TBL] [Abstract][Full Text] [Related]
17. Splenic marginal zone lymphoma leads to sinistral portal hypertension.
Lv XH; Ma LL; Fu WY; Xie Y
J Dig Dis; 2019 Jan; 20(1):45-48. PubMed ID: 30549195
[No Abstract] [Full Text] [Related]
18. [Splenic marginal zone lymphoma].
Dimopoulos K; Pedersen M
Ugeskr Laeger; 2012 Oct; 174(40):2383-6. PubMed ID: 23031300
[TBL] [Abstract][Full Text] [Related]
19. Splenic marginal zone lymphoma masquerading as cirrhotic hypersplenism for seven years.
Carr JA
Can J Gastroenterol; 2012 Mar; 26(3):123-4. PubMed ID: 22462122
[No Abstract] [Full Text] [Related]
20. Unusual direct phycoerythrin labeling of B-cells from a splenic marginal zone lymphoma.
Tabary T; Staal-Viliare A; Rault JP; Didion J; Latger-Cannard V; Reveil B; Cohen JH; Rio Y
Cytometry B Clin Cytom; 2008 May; 74(3):189-93. PubMed ID: 18061954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
